You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

May 20, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Asthma risk higher in children given antibiotics in their first year of life

Kids exposed to antibiotics in the first year of life had double the risk of developing early-onset childhood asthma, according to a study published online in Annals of Allergy, Asthma & Immunology. » Full article

Indication-specific alternatives help combat shortage of IV metronidazole antibiotic

There has been a recent national backorder of IV metronidazole (Flagyl) due to manufacturing delays with Hospira. » Full article

Continuing Education

MTM essentials for hypertension—Part 2: Drug therapy considerations

This month's article is the fourth in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to discuss place in therapy of drug classes used to treat hypertension and review drug considerations of prescription antihypertensive mediations and herbal supplements that are relevant to medication therapy management of hypertension.

To read and print the article with TEST QUESTIONS, click here.
To proceed to the online exams and earn up to 2 CPE credits, click here to log in.


Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

 

Related Articles

Tiotropium for asthma: Appears to be effective adjunct in phase 3 studies

IV nitroglycerin shortage concerning, but manageable

RESOURCES

Latest Clinical News

EDITOR'S PICK

FDA recommends lower starting dose for Lunesta

FDA has required the manufacturer of sleep drug eszopiclone (Lunesta) to lower the starting dose from 2 mg to 1 mg. » Full article

Powered by Modern Medicine Advanstar Medical Communications Group